OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia
Michał Zarobkiewicz, Wioleta Kowalska, Sylwia Chocholska, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2614-2614
Open Access | Times Cited: 23

Showing 23 citing articles:

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
Shifen Wang, Xingyun Zhao, Siwen Wu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 26

Tumor microenvironment as niche constructed by cancer stem cells: Breaking the ecosystem to combat cancer
Hao Zhong, Shiyue Zhou, Shuangshuang Yin, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5

γδ T Are Significantly Impacted by CLL Burden but Only Mildly Influenced by M-MDSCs
Michał Zarobkiewicz, Wioleta Kowalska, Agata Szymańska, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 254-254
Open Access

Characterisation of Cytotoxicity-Related Receptors on γδ T Cells in Chronic Lymphocytic Leukaemia
Michał Zarobkiewicz, Natalia Lehman, Izabela Morawska, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 451-451
Open Access

Decreased circulating myeloid-derived suppressor cell count at the engraftment is one of the risk factors for multiple myeloma relapse after autologous hematopoietic stem cell transplantation
Т. В. Тыринова, Е. В. Баторов, Tatyana Aristova, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26362-e26362
Open Access | Times Cited: 3

Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia
Candida Vitale, Elia Boccellato, Lorenzo Comba, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3856-3856
Open Access | Times Cited: 16

New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology
Nikoleta Bizymi, Andreas Μ. Matthaiou, Angelos Matheakakis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5326-5326
Open Access | Times Cited: 11

Unraveling the Bone Tissue Microenvironment in Chronic Lymphocytic Leukemia
Paolo Giannoni, Cecilia Marini, Giovanna Cutrona, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5058-5058
Open Access | Times Cited: 6

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
Rong Fan, Nathan De Beule, Anke Maes, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10

The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)
Michał Zarobkiewicz, Agnieszka Bojarska−Junak
Cells (2022) Vol. 11, Iss. 4, pp. 661-661
Open Access | Times Cited: 7

Cross‐talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review
Saeid Taghiloo, Hossein Asgarian‐Omran
European Journal Of Haematology (2024) Vol. 113, Iss. 1, pp. 4-15
Open Access | Times Cited: 1

Expression of CD226 on γδ T cells is lower in advanced chronic lymphocytic leukemia and correlates with IgA, IgG and LDH levels
Michał Zarobkiewicz, Natalia Lehman, Wioleta Kowalska, et al.
Advances in Clinical and Experimental Medicine (2024) Vol. 34, Iss. 2
Open Access | Times Cited: 1

Circulating Myeloid Regulatory Cells: Promising Biomarkers in B-Cell Lymphomas
Juliette Ferrant, Faustine Lhomme, Simon Le Gallou, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 8

Reduced Percentage of CD14dimCD16+SLAN+ Monocytes Producing TNF and IL-12 as an Immunological Sign of CLL Progression
Wioleta Kowalska, Michał Zarobkiewicz, Waldemar Tomczak, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3029-3029
Open Access | Times Cited: 6

Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia?
Justyna Woś, Agata Szymańska, Natalia Lehman, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 30-30
Open Access | Times Cited: 3

The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
Peng Dong, Yu Yan, Yujun Fan, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 5

Prognostic Potential of Galectin-9 mRNA Expression in Chronic Lymphocytic Leukemia
Agnieszka Bojarska−Junak, Wioleta Kowalska, Sylwia Chocholska, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5370-5370
Open Access | Times Cited: 2

Prognostic Value of Tie2-Expressing Monocytes in Chronic Lymphocytic Leukemia Patients
Justyna Woś, Sylwia Chocholska, Wioleta Kowalska, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2817-2817
Open Access | Times Cited: 4

Emerging Roles of Immune Cells in Cancer Development and Progression
David Entenberg, Panagiota S. Filippou, George S. Karagiannis
Cancers (2022) Vol. 14, Iss. 11, pp. 2642-2642
Open Access | Times Cited: 1

The Yin-Yang of myeloid cells in the leukemic microenvironment: Immunological role and clinical implications
Fábio Magalhães-Gama, Fabíola Silva Alves-Hanna, Nilberto Dias de Araújo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1

Page 1

Scroll to top